Efficacy of osimertinib (osi) on (prevention of) bone metastases (mets) and skeletal related events (SREs) in patients (pts) with epidermal growth factor receptor mutated (EGFRm plus ) non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Brouns, A. [1 ]
Veelen, A. V. [2 ]
Veerman, M. [3 ]
Steendam, C. [3 ]
Dursun, S. [4 ]
Croes, S. [2 ]
Dingemans, A-M. C. [5 ]
Hendriks, L. [4 ]
机构：
[1] Zuyderland Med Ctr, Dept Pulm Dis, Heerlen, Netherlands
[2] Maastricht Univ Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands
[3] Univ Med Ctr Rotterdam, MC Canc Inst, Dept Resp Med, Rotterdam, Netherlands
[4] Maastricht Univ Med Ctr, Dept Pulm Dis, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands
[5] Erasmus MC, Univ Med Ctr Rot terdam, Dept Resp Med, Canc Inst, Rotterdam, Netherlands
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.02.057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
48P
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [1] Impact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy
    Lazzari, Chiara
    Gregorc, Vanesa
    Santarpia, Mariacarmela
    JOURNAL OF THORACIC DISEASE, 2019, 11 (11) : 4400 - 4403
  • [2] Understanding epidermal growth factor receptor mutation (EGFRm) testing in patients (pts) with non-small cell lung
    Nadler, Eric
    Fernandes, Ancilla
    Pavilack, Melissa
    Amirian, Susan
    Clark, Jamyia
    Frytak, Jennifer R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [3] Osimertinib a new weapon in epidermal growth factor receptor-mutated non-small cell lung cancer patients
    Rossi, Antonio
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S610 - S613
  • [4] RISK FACTORS FOR SKELETAL-RELATED EVENT (SRES) IN ZOLEDRONIC ACID-TREATED PATIENTS WITH BONE METASTASES (METS) FROM NON-SMALL CELL LUNG CANCER (NSCLC)
    Brown, J.
    Cook, R.
    Hirsh, V.
    Major, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 275 - 275
  • [5] Osimertinib in untreated epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer
    Gregorc, Vanesa
    Lazzari, Chiara
    Karachaliou, Niki
    Rosell, Rafael
    Santarpia, Mariacarmela
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S165 - S170
  • [6] The Role of Epidermal Growth Factor Receptor in the Onset of Skeletal Related Events in Non-Small Cell Lung Cancer
    Huang, Shu-Mei
    Yang, Jin-Ji
    Chen, Huajun
    Bai, Xiao-Yan
    Zhou, Qing
    Tu, Hai-Yan
    Wu, Yi Long
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1225 - S1226
  • [7] Epidermal growth factor receptor is associated with the onset of skeletal related events in non-small cell lung cancer
    Huang, Shu-Mei
    Yang, Jin-Ji
    Chen, Hua-Jun
    Wu, Si-Pei
    Bai, Xiao-Yan
    Zhou, Qing
    Tu, Hai-Yan
    Wu, Yi-Long
    ONCOTARGET, 2017, 8 (46) : 81369 - 81376
  • [8] RELAY plus : Exploratory study of ramucirumab plus gefitinib in untreated patients (pts) with epidermal growth factor receptor (EGFR)-mutated metastatic non-small cell lung cancer (NSCLC).
    Nishio, Makoto
    Nishio, Kazuto
    Reck, Martin
    Garon, Edward B.
    Imamura, Fumio
    Kawaguchi, Tomoya
    Yamaguchi, Hiroyuki
    Ikeda, Satoshi
    Hirano, Katsuya
    Visseren-Grul, Carla M.
    Widau, Ryan C.
    Zimmermann, Annamaria H.
    Homma, Gosuke
    Enatsu, Sotaro
    Nakagawa, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Epidermal growth factor receptor (EGFR) mutation testingin non-small cell lung cancer (NSCLC) patients (pts).
    Sequist, L. V.
    Joshi, V. A.
    Jänne, P. A.
    Fidias, P.
    Muzikansky, A.
    Meyerson, M.
    Haber, D. A.
    Kucherlapati, R.
    Johnson, B. E.
    Lynch, T. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 408S - 408S
  • [10] OUTCOME OF EPIDERMAL GROWTH FACTOR RECEPTOR MUTATED (EGFRM) NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (P) WITH BRAIN METASTASES (BM) IN A SINGLE INSTITUTION: VALUE OF THE LUNG-GPA CLASSIFICATION
    Jove, Maria
    Navarro, Arturo
    Dolores Arnaiz, Maria
    Plana, Maria
    Brao, Isabel
    Codorniu, Nuria
    Navarro-Perez, Valenti
    Palmero, Ramon
    Cardenal, Felipe
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S838 - S838
12345